![]() |
Jennifer (Yujia) Jiang
Ms. Jiang is an associate in Davis Polk's Corporate Department, currently practicing as a Registered Foreign Lawyer in Hong Kong. |
Work Highlights
Recent Representations
- Antengene's $357 million Hong Kong IPO and global offering
- RemeGen's $514.3 million Hong Kong IPO and global offering
- InnoCare Pharma's $287 million Hong Kong IPO and global offering
- LIZHI INC's $45.1 million SEC-registered IPO on Nasdaq
- DouYu's $775 million SEC-registered U.S. IPO on Nasdaq
- CStone Pharmaceuticals' $285 million Hong Kong IPO and global offering
- CNFinance's $51.94 million SEC-registered U.S. IPO on the NYSE
- DuPont Fabros Technology, Inc. $200 million SEC-registered at-the-market offering
- Johnson Controls International plc $500 million senior notes offering
Professional History
- Davis Polk since 2014